Targeted DNA RNA Sequencing Market Size Worth USD 70.79 Billion by 2034 | CAGR: 19.4%

The global targeted DNA RNA sequencing market size is expected to reach USD 70.79 billion by 2034, according to a new study by Polaris Market Research. The report “Targeted DNA RNA Sequencing Market Size, Share, Trends, Industry Analysis Report: By Type (DNA-Based and RNA-Based), Method, Workflow, End User (Academic Research, Hospitals & Clinics, Pharma & Biotech Entities, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The targeted DNA/RNA sequencing market is experiencing robust growth, driven by advancements in next-generation sequencing (NGS) technologies, increasing demand for personalized medicine, and the rising prevalence of genetic disorders and cancer. The market benefits from opportunities in drug discovery, companion diagnostics, and the expanding application of sequencing in clinical settings.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/targeted-dna-rna-sequencing-market/request-for-sample

The integration of AI and bioinformatics for data analysis, the development of cost-effective sequencing platforms, and growing interest in single-cell sequencing are expected to emerge as key trends in the market during the forecast period. Overall, the market is set for substantial expansion, underpinned by continuous innovation and the broader adoption of precision medicine.

Targeted DNA RNA Sequencing Market Report Highlights

• Based on type, the DNA-based segment dominates the market due to its extensive application in clinical diagnostics and research. The RNA-based segment is witnessing rapid growth, driven by its increasing use in transcriptomics and gene expression studies.
• The exome sequencing segment, by method, leads the market, as it is widely adopted for identifying genetic variations linked to diseases. However, the amplicon sequencing segment is gaining traction for its cost-effectiveness and targeted approach, particularly in cancer research.
• The sequencing segment, in terms of workflow, holds the largest market share, benefiting from technological advancements and reduced costs. Data analysis is the fastest-growing segment, propelled by the need for robust bioinformatics tools to handle complex sequencing data.
• By end user, the academic research segment holds the largest market share due to ongoing genomic studies and research funding. The pharma & biotech entities segment is the fastest-growing segment, leveraging sequencing for drug development and personalized medicine.
• North America dominates the market, driven by advanced healthcare infrastructure and significant R&D investments. Asia Pacific is the fastest-growing region, with increasing adoption of sequencing technologies in emerging economies such as China and India.

Polaris Market Research has segmented the targeted DNA RNA sequencing market report on the basis of type, method, workflow, end user, and region:

By Type Outlook (Revenue – USD Billion, 2020–2034)

• DNA-Based
• RNA-Based

By Method Outlook (Revenue – USD Billion, 2020–2034)

• Exome Sequencing
• Enrichment Sequencing
• Amplicon Sequencing
• Others

By Workflow Outlook (Revenue – USD Billion, 2020–2034)

• Pre-sequencing
• Sequencing
• Data Analysis

By End User Outlook (Revenue – USD Billion, 2020–2034)

• Academic Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Others

By Regional Outlook (Revenue – USD Billion, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  •  India
  •  Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Targeted DNA RNA Sequencing Market Report Scope